0000899243-23-004343.txt : 20230208
0000899243-23-004343.hdr.sgml : 20230208
20230208192413
ACCESSION NUMBER: 0000899243-23-004343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230206
FILED AS OF DATE: 20230208
DATE AS OF CHANGE: 20230208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Madaus Martin D
CENTRAL INDEX KEY: 0001310268
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 23600603
MAIL ADDRESS:
STREET 1: 290 CONCORD ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-06
0
0000730272
REPLIGEN CORP
RGEN
0001310268
Madaus Martin D
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
1
0
0
0
Common Stock
2023-02-06
4
A
0
111
0.00
A
111
D
Stock Option (Right to Buy)
192.02
2023-02-06
4
A
0
239
0.00
A
2023-05-18
2033-02-06
Common Stock
239
239
D
Stock Option (Right to Buy)
192.02
2023-02-06
4
A
0
1819
0.00
A
2024-02-06
2033-02-06
Common Stock
1819
1819
D
Mr. Madaus was awarded 111 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 18, 2023, the date of the annual meeting of the Company's shareholders. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Award vests in full on May 18, 2023, the date of the annual meeting of the Company's shareholders.
The shares vest in equal annual instalments over a three-year period with each such vesting date occurring on the earlier of the anniversary of the grant date or the date of the annual meeting of the Company's shareholders of the applicable year of such three-year period.
/s/ Kimberly Brown (Attorney in Fact)
2022-02-08